Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
- PMID: 9371490
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
Abstract
Sporadic prostate carcinoma is the most common male cancer in the Western world, yet many of the major genetic events involved in the progression of this often fatal cancer remain to be elucidated. Numerous cytogenetic and allelotype studies have reported frequent loss of heterozygosity on chromosomal arm 10q in sporadic prostate cancer. Deletion mapping studies have unambiguously identified a region of chromosome 10q23 to be the minimal area of loss. A new tumor suppressor gene, PTEN/MMAC1, was isolated recently at this region of chromosome 10q23 and found to be inactivated by mutation in three prostate cancer cell lines. We screened 80 prostate tumors by microsatellite analysis and found chromosome 10q23 to be deleted in 23 cases. We then proceeded with sequence analysis of the entire PTEN/MMAC1 coding region and tested for homozygous deletion with new intragenic markers in these 23 cases with 10q23 loss of heterozygosity. The identification of the second mutational event in 10 (43%) tumors establishes PTEN/MMAC1 as a main inactivation target of 10q loss in sporadic prostate cancer.
Similar articles
-
Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.Cancer Res. 1998 Jan 15;58(2):204-9. Cancer Res. 1998. PMID: 9443392
-
PTEN/MMAC1 mutations in endometrial cancers.Cancer Res. 1997 Nov 1;57(21):4736-8. Cancer Res. 1997. PMID: 9354433
-
Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.Genes Chromosomes Cancer. 2004 Mar;39(3):171-84. doi: 10.1002/gcc.10311. Genes Chromosomes Cancer. 2004. PMID: 14732919
-
Genetic changes associated with prostate cancer in humans.Cancer Surv. 1991;11:15-24. Cancer Surv. 1991. PMID: 1841750 Review.
-
Tumour suppressor genes in prostate cancer.Semin Cancer Biol. 1997 Feb;8(1):11-9. doi: 10.1006/scbi.1997.0048. Semin Cancer Biol. 1997. PMID: 9299577 Review.
Cited by
-
The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way.Prostate. 2013 Feb 15;73(3):267-77. doi: 10.1002/pros.22566. Epub 2012 Jul 20. Prostate. 2013. PMID: 22821817 Free PMC article.
-
E17K substitution in AKT1 in prostate cancer.Br J Cancer. 2010 May 11;102(10):1491-4. doi: 10.1038/sj.bjc.6605673. Epub 2010 Apr 20. Br J Cancer. 2010. PMID: 20407443 Free PMC article.
-
SIX1 Regulates Aberrant Endometrial Epithelial Cell Differentiation and Cancer Latency Following Developmental Estrogenic Chemical Exposure.Mol Cancer Res. 2019 Dec;17(12):2369-2382. doi: 10.1158/1541-7786.MCR-19-0475. Epub 2019 Oct 9. Mol Cancer Res. 2019. PMID: 31597742 Free PMC article.
-
Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.J Med Genet. 2000 May;37(5):336-41. doi: 10.1136/jmg.37.5.336. J Med Genet. 2000. PMID: 10807691 Free PMC article.
-
Methylation matters.J Med Genet. 2001 May;38(5):285-303. doi: 10.1136/jmg.38.5.285. J Med Genet. 2001. PMID: 11333864 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials